Catalent's Martin De Brauwere and Maria Lopez react to cell therapy innovations and highlight strategies to optimize the drug development and manufacturing process with assistance from a CDMO.
LEARN MORE IN THIS VIDEO:
- Current state of the cellular therapy market and challenges bringing newer therapies to commercialization
- Critical components tied to successful drug development and manufacturing of cell therapies
- Remaining current with regulatory guidance tied to cell therapies
- Proper oversight of supply chains tied to a cell therapy project